cimicoxib has been researched along with dinoprostone in 1 studies
| Studies (cimicoxib) | Trials (cimicoxib) | Recent Studies (post-2010) (cimicoxib) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
|---|---|---|---|---|---|
| 16 | 7 | 13 | 29,105 | 1,346 | 6,357 |
| Protein | Taxonomy | cimicoxib (IC50) | dinoprostone (IC50) |
|---|---|---|---|
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
| Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
| Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
| Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
| Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Della Rocca, G; Di Salvo, A; Giorgi, M; Kim, TW; Ryschanova, R; Sgorbini, M | 1 |
1 other study(ies) available for cimicoxib and dinoprostone
| Article | Year |
|---|---|
Evaluation of pharmacokinetic and pharmacodynamic properties of cimicoxib in fasted and fed horses.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Dinoprostone; Dose-Response Relationship, Drug; Female; Food Deprivation; Half-Life; Horses; Imidazoles; Pilot Projects; Sulfonamides; Thromboxane B2 | 2015 |